Get ready for the return the region's most successful laboratory and analytical technology event!
 
 
The biomedical sciences industry in the region has been showing promising growth and is expected to continue for many years. Asia is also heading up with massive developments in the chemical & petrochemical, engineering, environment and life sciences clusters, which are driving the demand for innovative laboratory and analytical technologies and services.
 
AnaLabAsia2007 aims to take your company to the heart of these markets and explore the business prospects available in fulfilling the industry's sizeable demand for innovative laboratory and analytical technologies and services.
 
 
Market Statistics:
 
Take advantage of the ever-increasing demand in these countries:
 
Indonesia
State power utility company PT Perusahaan Listrik Negara (PLN) plans to spend US$1.6 billion to build four or five gas-fired power plants in Java and Sumatra. The company is expected to allocate some US$400 million on each plant, which will have a capacity of about 750MW. The plants are expected to be in operation by 2010 or 2011.www.the-eic.com,6 July 2005
 
Malaysia
Petronas is planning to invest US$600 million to construct an oil & gas terminal as well as an ammonia and urea plant in Sabah.
www.the-eic.com, 21 September 2005
 
Singapore
Shell and its project partner, the Economic Development Board, are finalizing investors for the downstream plants at their planned multibillion-dollar Singapore petrochemical complex. Its new world-scale ethylene cracker on Bukom Island and world-scale monoethylene glycol plant are expected to be operational in mid 2009.
Business Times, 8 March 2006
 
Thailand
Rayong Refinery Plc and Aromatics (Thailand) Plc have signed a huge deal, whereby they will jointly boost their capacity through the investment of US$1.07 billion (Bt42 billion). Rayong Refinery will build a reforming plant worth $387 million and an upgrading plant valued at $135 million, while Aromatics will build an aromatics plant worth $551 million.
The Nation, 16 February 2006
 
Vietnam
The Vietnamese government will pump more capital to several key oil and gas projects in the country in an effort to increase domestic petroleum production and minimise imports. Dung Quat Oil Refinery, its first oil refinery, is expected to receive US$2.27 billion.
vibforum.vcci.com.vn, 4 January 2006
 
Considering the dramatic growth and development of the life sciences and biotechnology industry in Asia, there are enormous business opportunities for life-science solutions providers, with research, biotechnology and pharmaceutical development of high priority.
 
Asia Pacific
The global life sciences industry is estimated to be worth about $2 trillion and the Asia Pacific region is fast catching up with double-digit growth rates. If healthcare services are excluded, the life sciences sector will be approximately $1 trillion and the Asia Pacific region has nearly quarter of the share.
www.biospectrumindia.co, 9 February 2006
 
India
Considering the inherent knowledge base and the strong enabling infrastructure in the country, it is estimated that the biotechnology market is expected to reach US$5 billion by the year 2010.
Chronicle Pharmabiz,2 February 2006
 
Malaysia
Budget 2006 has set the stage to launch biotechnology in a big way. Biotechnology is expected to generate RM270 million in revenue, create 280,000 jobs and establish 100 companies by 2020.
New Sunday Times, 9 October 2005
 
Singapore
Singapore's biotech sector is on track for robust growth. The sector is seen as a vital growth engine for the future,and the government has announced plans to double the amount of investments to the industry to S$12 billion over the next five years.
www.channelnewsasia.com, 6 March 2006
 
As part of the Science & Technology Plan 2010, Singapore will be spending S$13.55 billion over the next five years to boost research and development, of which $7.5 billion will go to Ministry of Trade & Industry to drive R&D growth in key industry areas such as biomedical science.
The Straits Times, 17 February 2006
 
CIA2005 Visitor Statistics:

Over 65% of visitors are involved in purchasing / recommending products and services
Over 90% of visitors found the event useful for their sourcing needs
Over 85% of the visitors are likely to purchase products and/or engage services at the show or in the near future

The CIA2005 visitors were from*: At CIA2005, visitors were interested to source for*:
Biotechnology/Life Sciences 10.03%
Chemical/Pharmaceutical Manufacturing 12.79%
Distributor/Manufacturer's Representative 21.13%
Electrical/Electronics Manufacturing 8.26%
Engineering & Contracting 12.81%
Environmental Management/Utilities/Water & Waste Management 7.08%
Food & Beverage Processing 2.87%
Machinery & Precision Equipment Manufacturing 3.64%
Petroleum Production
Research & Development/Trade
5.89%
Association/ Government Agency/Academia 7.33%
Heavy Industries & Others 8.17%
   
Actuators/Drives/Motors/Pumps 6.74%
Chemical/Solids Handling, Transport & Storage 5.64%
Design/Engineering/Contracting Services 4.39%
Environmental Control & Pollution Management 6.55%
Field Devices & Components 2.94%
Filtration & Separation Technology 5.76%
Heat Transfer Systems 2.90%
Industrial & Process Management Software 2.71%
Industrial Networks (Ethernet, Bus Technology) 1.90%
Instrumentation & Control Systems 9.13%
Lab Chemicals, Reagents and Supplies 7.66%
Laboratory Technology, Apparatus, Furniture & Fittings 8.44%
Measuring, Testing & Calibration 9.42%
Mixing & Dispensing Systems 2.71%
Pipes, Valves and Fittings 5.30%
Safety Equipment 4.88%
Scientific Equipment & Analytical Systems 8.24%
Sensors 4.43%
   
 
* All figures audited by PricewaterhouseCoopers
 
 
 
 
 
 
 
See Also
Exhibit Profile
Visitor Profile
ControlsAsia & InstrumentAsia 2007
Back to CIA
I Want to Book A Stand